
US-China Negotiations on Fentanyl Struggle Amid Trade War
The ongoing trade war between the United States and China has taken a new turn, with negotiations on addressing the fentanyl crisis hanging by a thread. The talks, which aimed to curb the flow of the highly addictive drug into the US, were reportedly marked by a lack of progress and frustration from US officials.
According to a report by Reuters, US and Chinese officials held talks in April 2025 to discuss measures to combat the fentanyl crisis, which has claimed thousands of lives in the US in recent years. However, US officials claimed that China did not negotiate in good faith, leading to a stalemate in the talks.
The US has long accused China of not doing enough to stop the production and export of fentanyl, a synthetic opioid that is often mixed with other drugs and can be 50-100 times more potent than morphine. China has denied the allegations, saying that the abuse of fentanyl in the US is a problem that must be confronted and resolved by the US itself.
The tensions surrounding the fentanyl crisis escalated further when US President Donald Trump threatened to impose a 20% tariff on China to curb the flow of fentanyl into the US. The threat was met with a stern response from China, which warned that such a move would harm US businesses and consumers.
The fentanyl crisis has become a major issue in the US, with the Drug Enforcement Administration (DEA) reporting that the country saw a 30% surge in fentanyl-related overdose deaths in 2024 compared to the previous year. The crisis has also had a significant impact on the US healthcare system, with hospitals and emergency services struggling to cope with the rising number of cases.
The US has accused China of not doing enough to stop the production and export of fentanyl, which is often manufactured in clandestine labs in Mexico and then shipped to the US. China has denied the allegations, saying that it has taken steps to crack down on the production and export of fentanyl, but that more needs to be done.
The Chinese government has also pointed out that the US has a significant problem with fentanyl abuse, and that the country needs to address the issue domestically rather than blaming China. The Chinese Foreign Ministry has said that the US needs to “take concrete actions to curb the spread of fentanyl” and to “refrain from making groundless accusations against China”.
The fentanyl crisis has also become a major issue in the 2024 US presidential election, with many candidates vowing to take tougher action to address the crisis. The crisis has also led to a renewed focus on the need for increased funding for drug treatment and prevention programs, as well as for law enforcement agencies that are working to combat the flow of fentanyl into the US.
In conclusion, the US-China negotiations on fentanyl have struggled to make progress amid the ongoing trade war. The US has accused China of not doing enough to stop the production and export of fentanyl, while China has denied the allegations and pointed out that the US has a significant problem with fentanyl abuse. The crisis has had a significant impact on the US healthcare system and has become a major issue in the 2024 US presidential election.
Sources: